Evidence map›Paper›PMID 29161989›Full record

ArticleToxicologic pathology2017

Comparison of Toxicity and Recovery in the Duodenum of B6C3F1 Mice Following Treatment with Intestinal Carcinogens Captan, Folpet, and Hexavalent Chromium.

Chad M Thompson, Jeffrey C Wolf, Alene McCoy, Mina Suh, Deborah M Proctor, Christopher R Kirman, Laurie C Haws, Mark A Harris

Open access · hybridAbstract read
In one paragraph

Article in Toxicologic pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Crypt and Villus Transcriptomic Responses in Mouse Small Intestine Following Oral Exposure to Hexavalent Chromium.Toxicological sciences : an official journal of the Society of Toxicology · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Chad M Thompson1 ToxStrategies, Inc., Katy, Texas, USA.
Jeffrey C Wolf2 Experimental Pathology Laboratories, Inc., Sterling, Virginia, USA.
Alene McCoy3 Charles River, Spencerville, Ohio, USA.
Mina Suh4 ToxStrategies, Inc., Mission Viejo, California, USA.
Deborah M Proctor4 ToxStrategies, Inc., Mission Viejo, California, USA.
Christopher R Kirman5 Summit Toxicology, LLP, Bozeman, Montana, USA.
Laurie C Haws6 ToxStrategies, Inc., Austin, Texas, USA.
Mark A Harris1 ToxStrategies, Inc., Katy, Texas, USA.
BioStrategies (United States) · USCharles River Associates · USExperimental Pathology Laboratories · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High concentrations of hexavalent chromium (Cr(VI)), captan, and folpet induce duodenal tumors in mice. Using standardized tissue collection procedures and diagnostic criteria, we compared the duodenal histopathology in B6C3F1 mice following exposure to these 3 carcinogens to determine whether they share similar histopathological characteristics. B6C3F1 mice ( n = 20 per group) were exposed to 180 ppm Cr(VI) in drinking water, 12,000 ppm captan in feed, or 16,000 ppm folpet in feed for 28 days. After 28 days of exposure, villous enterocyte hypertrophy and mild crypt epithelial hyperplasia were observed in all exposed mice. In a subset of mice allowed to recover for 28 days, duodenal samples were generally indistinguishable from those of unexposed mice. Changes in the villi and lack of observable damage to the crypt compartment suggest that toxicity was mediated in the villi, which is consistent with earlier studies on each chemical. These findings indicate that structurally diverse agents can induce similar (and reversible) phenotypic changes in the duodenum. These intestinal carcinogens likely converge on common pathways involving irritation and wounding of the villi leading to crypt regenerative hyperplasia that, under protracted high-dose exposure scenarios, increases the risk of spontaneous mutation and tumorigenesis.

Indexed as

Administration, OralAnimalsCaptanCarcinogensChromiumDose-Response Relationship, DrugDuodenumFemaleIntestinal MucosaMice, Inbred StrainsPhthalimidesCaptanCarcinogensChromiumchromium hexavalent ionfolpetPhthalimidesadverse outcome pathwaycaptancarcinogenesisduodenumfolpethexavalent chromiummode of action

Identifiers

PMID29161989
PMCPMC5761716
OpenAlexW2769142289

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.